Skip to Content
Medical Term:

Canavan disease

Pronunciation: kan'a-van


progressive degenerative disease of infancy; mostly affecting Ashkenazi Jewish babies; onset typically within the first 3–4 months of birth; characterized by megalencephaly, optic atrophy, blindness, psychomotor regression, hypotonia, and spasticity; there is increased urinary excretion of N-acetylaspartic acid. MRI shows enlarged brain, decreased attenuation of cerebral and cerebellar white matter, and normal ventricles; pathologically, there are increased brain volume and weight and spongy degeneration in the subcortical white matter. Autosomal recessive inheritance, caused by mutation in the aspartoacyclase A gene (ASPA) on chromosome 17p in Jewish and non-Jewish affected people.

Synonym(s): Canavan sclerosis, Canavan-van Bogaert-Bertrand disease, spongy degeneration of infancy

See Also: leukodystrophy

© Copyright 2017 Wolters Kluwer. All Rights Reserved. Review Date: Sep 19, 2016.